Thaiss, Wolfgang M. http://orcid.org/0000-0002-0796-780X
Gatidis, Sergios
Sartorius, Tina
Machann, Jürgen
Peter, Andreas
Eigentler, Thomas K.
Nikolaou, Konstantin
Pichler, Bernd J.
Kneilling, Manfred http://orcid.org/0000-0001-9119-1970
Funding for this research was provided by:
Universitätsklinikum Tübingen
Article History
Received: 28 July 2020
Accepted: 15 October 2020
First Online: 1 November 2020
Compliance with ethical standards
:
: W.M.T. declares that he has no conflicts of interest. S.G. declares that he has no conflicts of interest. T.S. declares that she has no conflicts of interest. J.M. declares that he has no conflicts of interest. A.P. declares that he has no conflicts of interest. T.K.E. declares that he has no conflicts of interest. K.N. declares that he has no conflicts of interest. B.J.P. receives grant/research support from: AstraZeneca, Bayer Healthcare, Boehringer-Ingelheim, Bruker, Oncodesign, Merck and Siemens; however, none of the grants are directly related to this work. M.K. declares that he has no conflicts of interest.
: All animal experiments were performed according to the German Animal Protection Law with permission from the local authorities (Regierungspräsidium Tübingen, Germany). The clinical study was approved by the appropriate local ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants obtained an informed consent of the study prior to treatment. Informed consent included the written permission to use the tumor samples of the patients included in the study for research purposes.